Literature DB >> 24219804

Low serum BDNF levels in depressed patients cannot be attributed to individual depressive symptoms or symptom cluster.

B A A Bus1, M L Molendijk, B W J H Penninx, J K Buitelaar, J Prickaerts, B M Elzinga, R C Oude Voshaar.   

Abstract

OBJECTIVES: Low serum BDNF levels have been found in depressed patients. No study has systematically investigated whether individual symptoms or symptom profiles within a depressed population contribute to low BDNF levels found in depressed subjects.
METHODS: All 1070 patients with a past 6-month diagnosis of major depressive disorder from the Netherlands Study of Depression and Anxiety (NESDA) were included. Composite International Diagnostic Interview (CIDI) and Inventory of Depressive Symptoms (IDS) items were tested individually in separate multiple regression analyses with serum BDNF level as the dependent and the CIDI or IDS item as independent variable. Subsequently, we compared BDNF levels between patients with seasonal affective disorder (based on the Seasonal Pattern Assessment Questionnaire) and melancholic depression, atypical depression and moderate depression (based on a latent class analysis). All analyses were adjusted for confounders.
RESULTS: Only one item was significantly associated with serum BDNF levels, namely the CIDI item "loss of interest" (β = 0.14; P < 0.01). Counterintuitively the presence of this symptom was associated with higher BDNF levels. Other items and the comparison between different types of depression did not reveal significant differences.
CONCLUSIONS: Decreased serum BDNF levels in depression cannot be attributed to a specific symptom or symptom cluster.

Entities:  

Keywords:  BDNF; atypical depression; depression; melancholic depression; seasonal affective disorder

Mesh:

Substances:

Year:  2013        PMID: 24219804     DOI: 10.3109/15622975.2013.841994

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  5 in total

1.  Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure.

Authors:  Lucas Spanemberg; Marco Antonio Caldieraro; Edgar Arrua Vares; Bianca Wollenhaupt-Aguiar; Márcia Kauer-Sant'Anna; Sheila Yuri Kawamoto; Emily Galvão; Gordon Parker; Marcelo P Fleck
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-19       Impact factor: 2.570

2.  Temporal regulation of peripheral BDNF levels during cocaine and morphine withdrawal: comparison with a natural reward.

Authors:  Hélène Anne-Sophie Geoffroy; Stephanie Puig; Nadia Benturquia; Florence Noble
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-07       Impact factor: 5.176

3.  Plasma brain-derived neurotrophic factor (BDNF) concentration and the BDNF Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder.

Authors:  Ming Ai; Jun Wang; Jianmei Chen; Wo Wang; Xiaoming Xu; Yao Gan; Xuemei Li; Xinyuan Gou; Jun Cao; Zhen Lv; Xiaorong Chen; Hengguang Wang; Qing Ma; Li Kuang
Journal:  Pharmgenomics Pers Med       Date:  2019-07-02

4.  Predicting the naturalistic course of depression from a wide range of clinical, psychological, and biological data: a machine learning approach.

Authors:  Richard Dinga; Andre F Marquand; Dick J Veltman; Aartjan T F Beekman; Robert A Schoevers; Albert M van Hemert; Brenda W J H Penninx; Lianne Schmaal
Journal:  Transl Psychiatry       Date:  2018-11-05       Impact factor: 6.222

5.  Traumatic grief research and care in the aftermath of the COVID-19 pandemic.

Authors:  A A A Manik J Djelantik; Eric Bui; Maja O'Connor; Rita Rosner; Donald J Robinaugh; Naomi M Simon; Paul A Boelen
Journal:  Eur J Psychotraumatol       Date:  2021-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.